EAAT2 activator 1
CAS No. 892415-28-0
EAAT2 activator 1( F2005-0304 | 3-[(2-Chloro-6-fluorobenzyl)thio]-6-pyridin-2-ylpyridazine )
Catalog No. M28620 CAS No. 892415-28-0
F2005-0304 is a thiopyridazine derivative that has been found to increase EAAT2 protein levels in astrocytes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 31 | Get Quote |
|
| 5MG | 50 | Get Quote |
|
| 10MG | 87 | Get Quote |
|
| 25MG | 178 | Get Quote |
|
| 50MG | 330 | Get Quote |
|
| 100MG | 491 | Get Quote |
|
| 500MG | 1071 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEAAT2 activator 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionF2005-0304 is a thiopyridazine derivative that has been found to increase EAAT2 protein levels in astrocytes.
-
DescriptionF2005-0304 is a thiopyridazine derivative that has been found to increase EAAT2 protein levels in astrocytes.
-
In Vitro——
-
In Vivo——
-
SynonymsF2005-0304 | 3-[(2-Chloro-6-fluorobenzyl)thio]-6-pyridin-2-ylpyridazine
-
PathwayOthers
-
TargetOther Targets
-
RecptorBD1-BRD4|BRD4-BD2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number892415-28-0
-
Formula Weight331.8
-
Molecular FormulaC16H11ClFN3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (75.35 mM)
-
SMILESFc1cccc(Cl)c1CSc(cc1)nnc1-c1ncccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kharenko OA, et al. Design and Characterization of Novel Covalent Bromodomain and Extra-Terminal Domain (BET) Inhibitors Targeting a Methionine. J Med Chem. 2018 Sep 27;61(18):8202-8211.
molnova catalog
related products
-
Mulberrofuran G
Mulberrofuran G shows moderate activity, inhibits hepatitis B virus (HBV) DNA replication with the IC(50) value of 3.99 μM.
-
Calcium Levofolinate
Calcium Levofolinate, a calcium salt of the folinic acid, is used in cancer chemotherapy as an adjuvant.
-
ADWX 1
Potent and selective KV1.3 channel blocker (IC50 values are 0.0019 and 0.65 nM for KV1.3 and KV1.1, respectively). Inhibits CD4+ CCR7- T cell activation. Ameliorates rat experimental autoimmune encephalomyelitis, in a model for multiple sclerosis.
Cart
sales@molnova.com